CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
In: Cancers 14.2 (2022): 326.
Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Dissertation, 2022
- Keyword
-
Cancer
Radiotherapy
CRISPR-associated protein 9
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2022
- Creator
- Contributor
-
Pilarsky, Christian
- URN
-
urn:nbn:de:bvb:29-opus4-196992
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lan, Bin
- Pilarsky, Christian
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2022
Other Objects (12)
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities
CRISPR/Cas9 in Gastrointestinal Malignancies
CRISPR-Cas9 and T cells
An Efficient Visual Screen for CRISPR/Cas9 Activity in Arabidopsis thaliana
CRISPR–Cas9 screens reveal regulators of ageing in neural stem cells
ShrinkCRISPR: a flexible method for differential fitness analysis of CRISPR-Cas9 screen data
CRISPR/CAS9 : Erbgut auf dem Schneidetisch
CRISPR-Cas9 fusions for synthetic epigenetics
In vivo CRISPR/Cas9 mediated screen for novel cancer genes in cholangiocarcinoma
CRISPR-Cas9 knockout screen informs efficient reduction of the Komagataella phaffii secretome
Clonal dynamics limits detection of selection in tumour xenograft CRISPR/Cas9 screens
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities
CRISPR/Cas9 in Gastrointestinal Malignancies
CRISPR-Cas9 and T cells
An Efficient Visual Screen for CRISPR/Cas9 Activity in Arabidopsis thaliana
CRISPR–Cas9 screens reveal regulators of ageing in neural stem cells
ShrinkCRISPR: a flexible method for differential fitness analysis of CRISPR-Cas9 screen data
CRISPR/CAS9 : Erbgut auf dem Schneidetisch
CRISPR-Cas9 fusions for synthetic epigenetics
In vivo CRISPR/Cas9 mediated screen for novel cancer genes in cholangiocarcinoma
CRISPR-Cas9 knockout screen informs efficient reduction of the Komagataella phaffii secretome
Clonal dynamics limits detection of selection in tumour xenograft CRISPR/Cas9 screens
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities
CRISPR/Cas9 in Gastrointestinal Malignancies
CRISPR-Cas9 and T cells
An Efficient Visual Screen for CRISPR/Cas9 Activity in Arabidopsis thaliana
CRISPR–Cas9 screens reveal regulators of ageing in neural stem cells
ShrinkCRISPR: a flexible method for differential fitness analysis of CRISPR-Cas9 screen data
CRISPR/CAS9 : Erbgut auf dem Schneidetisch
CRISPR-Cas9 fusions for synthetic epigenetics
In vivo CRISPR/Cas9 mediated screen for novel cancer genes in cholangiocarcinoma
CRISPR-Cas9 knockout screen informs efficient reduction of the Komagataella phaffii secretome